Jens Kaufmann

Title: Jens Kaufmann: Innovator in Radiopharmaceuticals

Introduction

Jens Kaufmann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 2 patents. His work focuses on innovative compositions and compounds that have the potential to improve diagnostic and therapeutic applications.

Latest Patents

Kaufmann's latest patents include a composition containing a somatostatin analogue for radiopharmaceutical use. This invention relates to a somatostatin analogue composition specifically designed for diagnostic or therapeutic purposes. More precisely, the somatostatin analogue is a receptor-selective somatostatin peptide antagonist. Another significant patent involves substituted cyclohexyldiamines, which are compounds that exhibit affinity to the μ-opioid receptor and the ORL 1-receptor. This invention also covers methods for their production, medications containing these compounds, and their use in treating pain or other medical conditions.

Career Highlights

Throughout his career, Jens Kaufmann has worked with prominent companies such as Gruenenthal GmbH and Ariceum Therapeutics GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Kaufmann has collaborated with talented individuals in his field, including Saskia Zemolka and Bert Nolte. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jens Kaufmann is a distinguished inventor whose work in radiopharmaceuticals has the potential to make a significant impact in medical diagnostics and treatment. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.